CAS Medical Systems, Inc. Report issue

For profit
Founded: Branford CT United States (1984)
Status: Acquired by Edwards Lifesciences (2019)

Organization Overview

First Clinical Trial
2009
NCT00938964
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Other Trials (1)

lidocaine (xylocaine) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1